We challenge long-held beliefs about fibroids, highlight new ectopic pregnancy nuances, and dig into real-world dermoid cyst outcomes. We also unpack the evidence and ethics of 39-week induction after IVF and ICSI, balancing small absolute risks with maternal tradeoffs.
• Evidence overturning links between fibroids and miscarriage, PROM and abruption
• Distinguishing spontaneous versus iatrogenic preterm birth in fibroid pregnancies
• Why myomectomy can raise early delivery and cesarean rates in some patients
• Ectopic care updates: tube-sparing choices, HCG thresholds, two-dose methotrexate
• Experimental adjuncts to methotrexate remain unproven
• Dermoid data supporting laparoscopy, irrigation, and specimen bags over open surgery
• Surgical decision making during pregnancy and avoiding uterine manipulators
• IVF and ICSI timing: late stillbirth risk signals, limits of testing, 39-week logic
• Shared decision making when absolute risks are low but values differ
Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram
1:33Fibroids And Miscarriage Myths
5:53Preterm Birth, PROM, And Hemorrhage
9:31Myomectomy: Risks, Scars, And Outcomes
13:25Ectopic Pregnancy: What’s New
18:37Surgery Versus Methotrexate Nuances
22:05Experimental Add-Ons To Medical Therapy
27:47Dermoid Cysts: Real-World Data
32:48Laparoscopy, Spillage, And Pregnancy
36:06When Open Surgery Makes Things Worse
40:34IVF, ICSI, And 39-Week Induction
48:05Stillbirth Risk: What The Data Shows
55:20Testing, Timing, And Shared Decisions
1:04:10Practical Counseling And Tradeoffs
Follow us on Instagram @thinkingaboutobgyn.
